Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.

Cabral ME, Figueroa LI, Fariña JI.

Rev Iberoam Micol. 2013 Jan 3;30(1):31-8. doi: 10.1016/j.riam.2012.09.006. Epub 2012 Oct 13.

PMID:
23069981
[PubMed - indexed for MEDLINE]
2.

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.

Nyilasi I, Kocsubé S, Krizsán K, Galgóczy L, Pesti M, Papp T, Vágvölgyi C.

FEMS Microbiol Lett. 2010 Jun;307(2):175-84. doi: 10.1111/j.1574-6968.2010.01972.x.

PMID:
20636975
[PubMed - indexed for MEDLINE]
3.
4.

Origin of differences in susceptibility of Candida krusei to azole antifungal agents.

Marichal P, Gorrens J, Coene MC, Le Jeune L, Vanden Bossche H.

Mycoses. 1995 Mar-Apr;38(3-4):111-7.

PMID:
7477085
[PubMed - indexed for MEDLINE]
5.

Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.

MacPherson S, Akache B, Weber S, De Deken X, Raymond M, Turcotte B.

Antimicrob Agents Chemother. 2005 May;49(5):1745-52.

PMID:
15855491
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.

Onyewu C, Blankenship JR, Del Poeta M, Heitman J.

Antimicrob Agents Chemother. 2003 Mar;47(3):956-64.

PMID:
12604527
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Characterization of an azole-resistant Candida glabrata isolate.

vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC.

Antimicrob Agents Chemother. 1992 Dec;36(12):2602-10.

PMID:
1482129
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.

Šimová Z, Poloncová K, Tahotná D, Holič R, Hapala I, Smith AR, White TC, Griač P.

Yeast. 2013 Jun;30(6):229-41. doi: 10.1002/yea.2956. Epub 2013 May 20.

PMID:
23606207
[PubMed - indexed for MEDLINE]
9.

The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J.

Antimicrob Agents Chemother. 1999 Nov;43(11):2753-65.

PMID:
10543759
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].

Kurnatowska AK, Kwaśniewska J.

Wiad Parazytol. 2009;55(4):415-23. Polish.

PMID:
20209818
[PubMed - indexed for MEDLINE]
11.

Growth inhibition of Candida species and Aspergillus fumigatus by statins.

Macreadie IG, Johnson G, Schlosser T, Macreadie PI.

FEMS Microbiol Lett. 2006 Sep;262(1):9-13.

PMID:
16907733
[PubMed - indexed for MEDLINE]
12.

Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.

Parker JE, Merkamm M, Manning NJ, Pompon D, Kelly SL, Kelly DE.

Antimicrob Agents Chemother. 2008 Oct;52(10):3597-603. doi: 10.1128/AAC.00517-08. Epub 2008 Aug 11.

PMID:
18694951
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.

Swinne D, Watelle M, Nolard N.

Rev Iberoam Micol. 2005 Mar;22(1):24-8.

PMID:
15813679
[PubMed - indexed for MEDLINE]
Free Article
14.

Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.

Venkateswarlu K, Denning DW, Kelly SL.

J Med Vet Mycol. 1997 Jan-Feb;35(1):19-25.

PMID:
9061581
[PubMed - indexed for MEDLINE]
15.

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole.

Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, Rossi L, De Pascale G, Curak J, Brown E, Tyers M, Wright GD.

Mol Syst Biol. 2011 Jun 21;7:499. doi: 10.1038/msb.2011.31.

PMID:
21694716
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs.

Zhang YQ, Gamarra S, Garcia-Effron G, Park S, Perlin DS, Rao R.

PLoS Pathog. 2010 Jun 3;6(6):e1000939. doi: 10.1371/journal.ppat.1000939.

PMID:
20532216
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.

Maesaki S, Marichal P, Hossain MA, Sanglard D, Vanden Bossche H, Kohno S.

J Antimicrob Chemother. 1998 Dec;42(6):747-53.

PMID:
10052898
[PubMed - indexed for MEDLINE]
Free Article
18.

Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.

Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.

Antimicrob Agents Chemother. 2012 Aug;56(8):4223-32. doi: 10.1128/AAC.06253-11. Epub 2012 May 21.

PMID:
22615281
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.

Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.

AIDS. 1994 Jul;8(7):945-50.

PMID:
7946104
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk